India has taken another step towards developing advanced medical imaging equipment within the country, with the Technology Development Board signing an agreement to support Panacea Medical Technologies Pvt. Ltd. in developing and commercialising an indigenous 32-slice computed tomography scanner.
The agreement was announced by the Department of Science and Technology on October 15, 2026. Panacea Medical Technologies, based in Malur, Karnataka, is an Indian medical-device manufacturer with experience in radiology, radiotherapy and technologies used in cancer treatment.
Editorial Insight
Key Highlights
Important points readers should notice.
Issue/Event: Government-backed development and commercialisation of an indigenous 32-slice CT scanner.
Location: Panacea Medical Technologies, Malur, Karnataka, India.
Authority/Organisation: Technology Development Board, Department of Science and Technology, Government of India, and Panacea Medical Technologies Pvt. Ltd.
Action Taken: TDB signed an agreement to support the development and commercialisation of the proposed diagnostic imaging system.
Impact: The project could strengthen India's domestic medical-imaging technology capabilities, subject to successful development, testing, regulatory compliance and commercial adoption.
The proposed scanner is intended for diagnostic imaging across various clinical disciplines. CT scanners use X-rays and digital detectors to produce cross-sectional images of the body. Computer systems reconstruct these measurements into detailed images that medical professionals can use to assess internal structures and support clinical decisions.
A 32-slice CT scanner captures multiple image sections during each rotation. Its practical performance depends on the complete system, including detector design, image reconstruction, scanning protocols, calibration and clinical requirements. The number of slices alone does not determine overall image quality or establish that a device is superior for every medical application.
Developing a diagnostic CT scanner requires the integration of several specialised technologies. These include X-ray generation, detector systems, precision mechanical components, image-processing software, electrical and thermal management, and controls designed to maintain safe operating conditions.
Editorial Analysis
Why This Matters
Advanced diagnostic equipment is an important part of modern healthcare infrastructure. The ability to develop and manufacture such systems domestically can support industrial capability, technical employment and a more resilient supply chain. For hospitals, the long-term value of a scanner depends on reliable imaging, patient safety, service availability and total operating costs. A locally developed system could offer another option if it meets those requirements and proves commercially viable. For India, the project is a step in medical-device development rather than proof that import dependence has already been reduced. Its significance will become clearer when technical performance, manufacturing readiness and regulatory progress are established.
The equipment must also undergo appropriate testing to assess imaging performance, reliability and radiation safety. Medical devices intended for clinical use must meet the applicable regulatory and quality requirements before being marketed or deployed.
Why India Wants to Develop CT Scanner Technology Domestically
CT imaging is used in hospitals and diagnostic centres to investigate a wide range of medical conditions. Depending on the clinical situation, scans can help doctors assess injuries, identify abnormalities, examine organs and support the diagnosis or monitoring of diseases.
Access to such equipment depends on more than the scanner's purchase price. Healthcare providers must also consider installation, maintenance, replacement parts, service support, software updates and the availability of trained personnel.
Domestic development can create opportunities to build technical expertise across the medical-device supply chain. If the project progresses successfully, it could contribute to India's manufacturing capabilities and provide another locally developed option for healthcare institutions.
However, the extent of any reduction in import dependence will depend on the final product's performance, manufacturing scale, component sourcing, cost, service network and acceptance by hospitals. An indigenous development project does not automatically mean that every component will be manufactured domestically.
Panacea's Existing Medical Technology Experience
Panacea Medical Technologies has experience in developing equipment for radiology and radiotherapy. The company is now expanding its work into diagnostic CT imaging through the proposed 32-slice scanner project.
The Technology Development Board has previously supported Panacea in medical technology projects, including the commercialisation of indigenous medical linear accelerator equipment. A medical linear accelerator is used in radiotherapy to deliver controlled radiation doses for cancer treatment; it serves a different purpose from a diagnostic CT scanner.
The new project therefore represents an expansion into another part of the medical imaging ecosystem. Experience in precision engineering and medical equipment manufacturing may be relevant, but the diagnostic scanner will need its own technical validation and regulatory pathway.
What the Government Support Means
The Technology Development Board operates under the Department of Science and Technology and supports the development and commercialisation of indigenous technologies. Its role is to help bridge the gap between technology development and products that can be manufactured and deployed.
For the CT scanner project, the agreement signals institutional support for developing domestic diagnostic imaging technology. The public announcement does not specify a confirmed market-launch date or establish that the scanner is already available to hospitals.
The next stages will be important in determining whether the project can move from development into a reliable, commercially viable medical device. These stages can include engineering refinement, system integration, testing, quality assurance and compliance with relevant regulatory requirements.
The development also reflects a broader challenge for India's medical-device industry: translating technical capability into products that healthcare providers can use safely and maintain over time.
